Rheumatology EHR

Track healing progress with integrated wound photography and time-stamped comparisons.

Rheumatology Workflow Automation Software

Rheumatology is one of the few fields where disease control depends on tracking imperceptible changes across years, not weeks. Our rheumatology practice software embeds validated tools like DAS28, BASDAI, SLEDAI, and RAPID3 directly into daily workflows.

Infusion suite automation synchronizes biologic dosing, refrigeration logs, and chair allocation with payer pre-authorizations, eliminating costly treatment delays. Integrated synovitis ultrasound scoring, MRI reviews, and longitudinal lab overlays create a single disease-trajectory timeline for every patient.

Predictive flare algorithms trained on rheumatology-specific datasets surface risks of RA, SLE, and PsA progression before they compromise mobility. Automated biologic-to-biosimilar switching pathways protect continuity while reducing financial toxicity.

Patient-reported outcomes on pain, stiffness, fatigue, and function feed directly into dashboards alongside labs and imaging for complete longitudinal care. Registry-ready data capture supports ACR/EULAR benchmarks, quality reporting, and clinical trial participation without adding clicks.

Patient Portal

Interoperability

Telehealth

Customized Order Set

Rheumatology EHR Software Interface

How OmniMD Supports Rheumatology Clinics

Rheumatology EMR

Tailored for systemic and joint disease care. Templates capture synovial counts, erosion scoring, infusion protocols, and imaging. Workflows simplify DMARD adjustments and biologic infusion tracking to match real clinical decisions.

Intelligent Scoring Integration

Activity indices like DAS28, BASDAI, and SLEDAI calculate in real time. Interactive diagrams map inflammation visually, highlighting flares and response trends. Supports proactive, precise treatment decisions beyond reactive observation.

Rheumatology Billing & Coding Software

Billing aligns with biologic therapies. Automated capture includes infusion times, dosing, and wastage. Built-in prior authorization reduces denials on costly biologics, safeguarding revenue while ensuring compliance across all treatments.

Remote Patient Monitoring

Captures daily data on stiffness, fatigue, and pain alongside HAQ-DI and RAPID3 indices. Longitudinal trends flag flare onset early, giving clinicians oversight between visits to intervene promptly and preserve disease control.

Rheumatology Clinic Management Software

Scheduling integrates with infusion chair availability, lab monitoring, and follow-up intervals unique to chronic autoimmune care. Patient records consolidate joint counts, biologic dosing history, and imaging timelines into one unified view. Clinical staff workflows, from intake to infusion room handoffs, mirror real-world rheumatology practice, ensuring no detail is missed.

Biologic Therapy Tracking Software

Every infusion, injection, and dose adjustment is logged with precision. Weight-based calculations, lot numbers, and administration routes are tracked in structured fields. Alerts surface for lab prerequisites, TB screening, and vaccination schedules before therapy initiation. Longitudinal dashboards reveal adherence patterns, wastage trends, and therapy response, closing the loop between safety, efficacy, and financial stewardship.

Real Stories From Medical Practices Thriving With OmniMD

After comparing many EMRs, I determined that OmniMD was the best software for my new clinic. I run a high volume family practice clinic. OmniMD is used for scheduling, reminder calls, medical records, insurance and patient billing. OmniMD is a critical tool for my practice. It is a very good software, but I am also very pleased with the level of service OmniMD provides with their technical support team.
Dawn K. Walker
D.O – Walker Family Medicine, PLC
Our practice has been very pleased with the outcomes of your billing and collection services. You have been both informative and patient as we continue to become a more efficient practice. We have recognized that collections have been improved due to your diligence and tenacity. Thank you for your kindness and hard work.
Maureen Lacey
Office Manager – Psychiatry Practice
OmniMD’s EHR and Billing software has truly simplified our operations at Solid Sobriety. Their billing tools have improved our efficiency, significantly reducing errors and boosting revenue. What stands out most is their exceptional customer support- the team is always available, knowledgeable, and proactive in solving any challenges we face. We couldn’t be happier with the partnership.
Brad Paley
Clinical Director – Solid Sobriety
I have been a practitioner for over a decade and worked various EMR programs in the past by far OmniMD surpasses all my expectations. It’s easy to manage and your entire note in one page with only a few clicks to complete. I own a family medical practice/ spa and I am very happy that I chose OmniMD. Their support staff is amazing they are always available to assist you.
Lucy Thompson
Rocky Hill Clinic Founder
As a new startup practice, we knew that selecting the right EHR system was crucial for establishing efficient workflows and direct patient care. OmniMD exceeded our expectations with its intuitive, customizable platform and outstanding customer support. From implementation to ongoing assistance, their team has been incredibly responsive, guiding us through every step and ensuring a smooth transition.
Brandy Cook, RN, FNP-C
Total Care & Weight Loss Clinic,
For more than a decade, OmniMD has been an integral part of our practice, offering a user-friendly software wireframe that makes charting extremely easy and enhancing our approach to out-of-network patients. The intuitive design and functionality have allowed us to improve patient care and operational efficiency significantly.
Dr. Ismail Alhamrawy, MD
Spine & Joint Pain Center
Hello, I’m Eman, for the past 10 years, OmniMD has been instrumental in transforming our billing operations. The reduction in claim denials and the ease of handling claims have not just simplified our work but have also allowed us to focus more on patient care. The efficiency and reliability that OmniMD offers are unparalleled, and it has been a vital component of our practice’s success.
Eman, Office Manager
Scotch Plains Medical Center

Who Should Use OmniMD Rheumatology EHR Software?

Solo and group rheumatology practices managing RA, SLE, and autoimmune disease: OmniMD’s disease-specific templates cover RA (DAS28, CDAI, HAQ), SLE (SLEDAI-2K), ankylosing spondylitis, psoriatic arthritis, and connective tissue diseases with condition-specific documentation fields rather than generic SOAP notes adapted from other specialties. MIPS measures #108, #109, #110, #111, and #177 are tracked automatically from structured note data without requiring a separate registry submission workflow.
Rheumatology practices with in-office infusion suites: Buy-and-bill biologic infusion is the highest-revenue service in most rheumatology practices and also the service most vulnerable to claim denial from incorrect J-codes, missing JW/JZ modifiers, and 96365-vs-96413 classification errors. OmniMD’s infusion suite module captures all required documentation fields, applies the correct administration code based on the drug’s chemo or non-chemo classification, and attaches JW or JZ based on documented vial usage. The AI revenue cycle management engine tracks denial patterns by drug and payer and generates root-cause reports for recurring infusion denials.
Practices managing biologic prior authorization renewals: Annual and semi-annual biologic PA renewals require current disease activity scores, updated lab safety results (CBC, hepatic panel, TB status), DMARD failure documentation, and a physician statement of ongoing medical necessity. OmniMD compiles all required PA elements automatically from the patient’s structured EHR data and submits the PA request through the integrated prior authorization workflow. Practices report a 40-60% reduction in PA preparation time when disease activity scores and lab safety data are captured as structured fields rather than narrative notes.
Rheumatology practices adding MIPS reporting or CCM revenue: Practices that are not currently reporting MIPS measures #108 and #111 may be leaving performance payment adjustments on the table. Practices that are not billing CCM (99490/99439) for their RA and SLE patients are leaving $60-$100 per patient per month unbilled for care coordination work that is already being performed. OmniMD enables both programs from existing structured visit data without adding documentation burden. See the EHR software overview and medical billing software pages for the complete rheumatology billing feature set.

Frequently Asked Questions

Yes. Our software is designed to flag discordant trends between biomarkers, imaging, and patient-reported outcomes, helping clinicians distinguish whether changes stem from RA, SLE, PsA, or an overlapping syndrome.
1111

Integrated workflows connect rheumatology with nephrology, dermatology, and pulmonology inputs for systemic diseases, consolidating cross-specialty findings into a single longitudinal record.

Longitudinal dashboards highlight micro-trends in labs, imaging, and patient inputs when DMARDs or biologics are tapered. This enables early detection of subclinical relapse before overt flares occur.

Yes. Templates and data capture are extended to conditions like systemic sclerosis, vasculitis, and autoinflammatory syndromes, ensuring full-spectrum rheumatology support rather than a narrow disease focus.

JW and JZ modifiers are mandatory on every single-use vial drug line submitted to Medicare and most commercial payers for biologic infusions. CMS enforced full compliance beginning January 1, 2023, and the requirement has been carried into all 2026 payer contracts. JZ applies when the entire vial is administered with no waste — the dose equals the full vial content and nothing is discarded. JW applies when a partial vial is administered and the unused portion is documented as discarded waste in the medical record. The waste amount must be noted in the infusion record with the specific volume discarded. Submitting neither modifier — or submitting JW without waste documentation — results in a claim denial or post-payment audit liability. OmniMD auto-selects JZ or JW based on the dose entered versus the vial size documented in the infusion record, and the infusion note includes a structured waste documentation field for any JW claim.

OmniMD supports all four validated disease activity scores accepted for MIPS measure #108 (RA: Disease Activity Assessment) and #111 (RA: Periodic Assessment of Disease Activity): DAS28 (using ESR or CRP), CDAI, SDAI, and RAPID3. The practice chooses the preferred scoring tool in the EHR configuration; the selected score then appears as a required field in the RA visit template. For MIPS #108, the score must be documented at least once during the measurement year. For MIPS #111, the score must be documented at two or more visits per year. OmniMD tracks the scoring frequency per eligible patient and generates a MIPS gap report monthly that flags patients approaching year-end without the required second documentation. The structured score data feeds the EHR’s registry module directly, eliminating manual data entry for registry submission.

The correct administration code depends on the drug’s classification, not on its route of administration. CPT 96365 (therapeutic, prophylactic, or diagnostic injection, IV infusion, first hour) applies to non-chemotherapy biologics commonly used in rheumatology: Infliximab (Remicade, J1745), Abatacept (Orencia IV, J0129), Tocilizumab (Actemra, J3262), and Belimumab (Benlysta, J0490). CPT 96413 (chemotherapy IV infusion, first hour) applies to drugs classified as chemotherapy agents even when used for non-oncologic rheumatologic indications: Rituximab (Rituxan, J9312) and its biosimilars (Truxima, Q5115; Ruxience). Using 96365 for Rituximab is an incorrect code selection that results in underpayment and payer audits. OmniMD maps each J-code and Q-code to its correct administration code in the drug database so the infusion suite module selects 96365 or 96413 automatically based on the drug administered, not based on manual coder selection.

OmniMD tracks each DMARD in the patient’s medication history with structured start date, stop date, and reason for discontinuation fields. For biologic PA requests, the system compiles a step-therapy summary automatically from the patient’s medication history: it lists each prior DMARD trial with dates, documented response, and reason for transition. Most commercial payers require demonstrated failure of at least two conventional DMARDs — typically methotrexate and hydroxychloroquine — before approving the first biologic for RA. Some payers also require leflunomide or sulfasalazine. The OmniMD PA module presents the compiled DMARD failure documentation alongside the current disease activity score, relevant lab safety data (CBC, hepatic panel, TB screening), and the provider’s clinical statement of medical necessity. For biologic renewals, the system pulls the prior PA approval date, the current DAS28 or CDAI score, and any adverse event documentation since the last approval to build the renewal request without manual chart review.

Yes. OmniMD’s rheumatology visit templates use separate, structurally independent sections for the E&M component and the procedure component. This separation is important because Modifier 25 requires that the E&M service represent a significant, separately identifiable evaluation and management service beyond what is included in the procedure. When both an E&M code (99213-99215) and a joint injection code (20600-20611) are generated from the same visit, OmniMD applies Modifier 25 to the E&M code automatically if the E&M note fields contain completed history, examination, and medical decision-making data. The E&M note must document disease activity review, medication management, lab result interpretation, or a plan change that is independent from the procedure documentation — a note that only describes the injection does not support the modifier. OmniMD flags E&M notes that lack sufficient independent documentation before the claim is submitted, allowing the provider to add content before the claim exits the practice.

J-codes are permanent HCPCS Level II codes assigned to original reference biologics — for example, J1745 for Infliximab (Remicade) or J9312 for Rituximab (Rituxan). Q-codes are temporary HCPCS codes assigned to biosimilar drugs that have received FDA approval but have not yet received a permanent J-code. As biosimilars of common rheumatology drugs have entered the market, CMS has assigned Q-codes: Q5103 for Inflectra (infliximab biosimilar), Q5115 for Truxima (rituximab biosimilar), and Q5101 for Hadlima (adalimumab biosimilar). Billing the reference biologic’s J-code when a biosimilar is administered is incorrect because payers cross-reference the drug NDC number on the claim against the HCPCS code. OmniMD’s drug database includes both J-codes and current Q-codes, updated when CMS releases new Q-code assignments. The practice selects the actual drug administered; the system applies the correct J-code or Q-code. JW or JZ applies equally to biosimilars under the same single-use vial rules as reference biologics.

Brands That Trust Us

Rheumatology EHR

Rheumatology Workflow Automation Software

Rheumatology EHR Software Interface